CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
GrOwnValve is pioneering a new heart valve technology by creating valves from patients' own tissue using 3D printing and medical imaging. This innovation aims to eliminate the risks of rejection and the need for multiple surgeries, particularly benefiting pediatric patients.
Each year 400,000 people are born with heart valve defects worldwide.
Moreover, in the western world, 1 in 8 healthy adults will develop a heart valve problem during their lifetime.
Current artificial heart valves made from animal or human donor tissue carry a high risk of tissue rejection, degradation and calcification that limit their lifespan to about 10 years, forcing patients to undergo risky cardiac re-surgery.
For children, no dedicated valve product exists, thus, paediatric patients can…
GROWNVALVE GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.